CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer
- 1 October 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9137) , 1358
- https://doi.org/10.1016/s0140-6736(05)60748-9
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Dendritic cells and the control of immunityNature, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Prostaglandin E2 and Tumor Necrosis Factor α Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 ProductionThe Journal of Experimental Medicine, 1997
- Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigenThe Prostate, 1996